Momenta shares plunge after supplier receives warning letter from FDA on multiple sclerosis drug
February 21, 2017 at 11:35 AM EST
Momenta says Pfizer, a key supplier for its multiple sclerosis drug, has received a warning letter from the Food and Drug Administration.